Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMX101 Vehicle vs Hydro-alcohol Solution in Acne Vulgaris
NCT03743038Phase 1Completed
- Sponsor
- Vyne Therapeutics
- Start
- Nov 2018
- Primary completion
- Feb 2019
- Modality
- Placebo
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of FMX101 vehicle in acne vulgaris (2 arms), sponsored by Vyne Therapeutics. Primary endpoints: Investigator's Global Assessment Score at Week 6, Investigator's Global Assessment Treatment Success at Week 6 and 8 more. Started Nov 2018; status: completed.
02
Drugs
FMX101 vehicle
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03743038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03743038.